Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Y Graham

Showing results (411-420 of 635) with videos related to

Pageof 64
Sort By:
Circulation|September 17, 1998
Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study InvestigatorsA R Folsom, F J Nieto, P Sorlie, et al.
The American Journal of Gastroenterology|November 1, 1987
Improved palliation of a respiratory-esophageal fistula with a cuffed esophageal prosthesisJ L Smith, P A Michaletz, N Tabibian, et al.
Helicobacter|January 8, 1998
Co-existing gastric cancer and duodenal ulcer disease: role of Helicobacter pylori infectionH Y Kim, Y B Kim, C K Park, et al.
Microbial Pathogenesis|November 11, 1991
Iron represses the expression of CFA/I fimbriae of enterotoxigenic E. coliT K Karjalainen, D G Evans, D J Evans, et al.
Scandinavian Journal of Gastroenterology|November 1, 1993
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer diseaseD Y Graham, K S Hepps, F C Ramirez, et al.
Journal of Bacteriology|February 1, 1993
Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pyloriD G Evans, T K Karjalainen, D J Evans, et al.
Journal of Clinical Microbiology|April 1, 1993
Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reactionA M Nguyen, L Engstrand, R M Genta, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2001
Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptyingA Shiotani, A Saeed, Y Yamaoka, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1997
Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infectionA M Segura, O Gutiérrez, W Otero, et al.
Scandinavian Journal of Gastroenterology|August 1, 1993
Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processingD Y Graham, M F Go, G M Lew, et al.
Pageof 64

Showing results (411-420 of 635) with videos related to

Sort By:
Pageof 64
Circulation|September 17, 1998
Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study InvestigatorsA R Folsom, F J Nieto, P Sorlie, et al.
The American Journal of Gastroenterology|November 1, 1987
Improved palliation of a respiratory-esophageal fistula with a cuffed esophageal prosthesisJ L Smith, P A Michaletz, N Tabibian, et al.
Helicobacter|January 8, 1998
Co-existing gastric cancer and duodenal ulcer disease: role of Helicobacter pylori infectionH Y Kim, Y B Kim, C K Park, et al.
Microbial Pathogenesis|November 11, 1991
Iron represses the expression of CFA/I fimbriae of enterotoxigenic E. coliT K Karjalainen, D G Evans, D J Evans, et al.
Scandinavian Journal of Gastroenterology|November 1, 1993
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer diseaseD Y Graham, K S Hepps, F C Ramirez, et al.
Journal of Bacteriology|February 1, 1993
Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pyloriD G Evans, T K Karjalainen, D J Evans, et al.
Journal of Clinical Microbiology|April 1, 1993
Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reactionA M Nguyen, L Engstrand, R M Genta, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2001
Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptyingA Shiotani, A Saeed, Y Yamaoka, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1997
Furazolidone, amoxycillin, bismuth triple therapy for Helicobacter pylori infectionA M Segura, O Gutiérrez, W Otero, et al.
Scandinavian Journal of Gastroenterology|August 1, 1993
Helicobacter pylori infection and exaggerated gastrin release. Effects of inflammation and progastrin processingD Y Graham, M F Go, G M Lew, et al.
Pageof 64